Comparison of Systemic and Transvaginal Local Methotrexate Treatment in Unruptured Ectopic Pregnancy.
- Author:
Jin Wan PARK
1
;
Yong Wook CHOI
;
Eui Jong HUR
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, Dan Kook University, Cheonan, Korea.
- Publication Type:Original Article
- Keywords:
Ectopic pregnancy;
Methotrexate;
Transvaginal sonography
- MeSH:
Female;
Gestational Sac;
Humans;
Medical Records;
Methotrexate*;
Pregnancy;
Pregnancy, Ectopic*
- From:Korean Journal of Obstetrics and Gynecology
2002;45(1):122-125
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: This study was performed to evaluate the efficacy of treating of unruptured ectopic pregnancy by systemic and transvaginal local administration of methotrexate. METHODS: We reviewed the medical records of 32 patients who were treated with methotrexate from June 1995 to October 1999. Among the patients, 14 were treated by ultrasound-guided transvaginal local injection and 18 were treated by systemic intramuscular administration. Success rate of the treatment was examined for each group, and the cases of methotrexate failure were characterized and compared with the success group. RESULTS: The success rate was similar between the transvaginal (85.7%) and the systemic (77.8%) groups. There were no differences in initial serum hCG levels, size of gestational sac, fetal cardiac activity between the success group and failure group. CONCLUSION: The results of this study suggest that there is no difference in efficacy between systemic and transvaginal local methotrexate administration, and there are no useful parameters in identifying the risk for the failure of methotrexate treatment.
